Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03646123
Title Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Seattle Genetics, Inc.

Hodgkin's lymphoma


Brentuximab vedotin + Dacarbazine + Doxorubicin + Filgrastim + Vinblastine

Brentuximab vedotin + Dacarbazine + Doxorubicin + Nivolumab

Age Groups: adult | child | senior
Covered Countries USA | ITA | ESP

No variant requirements are available.